The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta
Database / Awards

Federal awards

Every contract and grant ingested from USAspending.gov. Pick an agency to narrow the list; toggle Highest / Lowest to sort. Click any row to open the full award profile.

Sort by
Agency: Department of Health and Human ServicesStatus: Currently active
Results

1,131 awards

Showing 801850
Action dateRecipientAgencyAmountDescriptionSector
2026-04-20COMMERCE, WASHINGTON STATE DEPARTMENT OFDepartment of Health and Human Services$60,706,949LIHEAP-2026 - LOW INCOME HOME ENERGY ASSISTANCEsocial-services
2026-04-20REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THEDepartment of Health and Human Services$60,700,604THE ALZHEIMER'S DISEASE TAU PLATFORM CLINICAL TRIAL - PROJECT SUMMARY / ABSTRACT TAU PROTEIN IS AN ATTRACTIVE AD THERAPEUTIC TARGET BECAUSE THE AMOUNT AND ANATOMICAL DISTRIBUTION OF INSOLUBLE TAU AT AUTOPSY IS STRONGLY CORRELATED WITH THE SYMPTOMS AND SEVERITY OF DISEASE DURING LIFE. MULTIPLE TAU THERAPIES ARE NOW IN CLINICAL TRIALS FOR AD, WITH MANY NEW AGENTS ENTERING THE CLINIC. NEW APPROACHES TO ACCELERATING THEIR CLINICAL DEVELOPMENT ARE URGENTLY NEEDED. A VARIETY OF AD BIOMARKERS NOW EXIST, INCLUDING CSF AND PLASMA BETA AMYLOID RATIOS AND PHOSPHORYLATED TAU (P-TAU) LEVELS, AND AMYLOID AND TAU PET TRACERS, PROVIDING TOOLS TO MEASURE PHARMACODYNAMIC EFFECTS OF AMYLOID AND TAU THERAPIES ON THE CORE BIOLOGY OF AD. THE GOAL OF THE ALZHEIMER’S TAU PLATFORM (ATP) TRIAL IS TO CONDUCT A RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 PLATFORM TRIAL IN PRECLINICAL-PRODROMAL AD THAT WILL SIMULTANEOUSLY TEST AT LEAST TWO DIFFERENT TAU-DIRECTED THERAPIES, ALONE OR IN COMBINATION WITH AN ANTI-AMYLOID THERAPY, TO DETERMINE SAFETY, TOLERABILITY, AND BIOLOGICAL BASED PROOF OF CONCEPT BASED ON THE TAU PET TRACER 18F MK6240 AND OTHER TAU BIOMARKERS. PLATFORM TRIALS CREATE EFFICIENCIES THROUGH GENERATION OF A COMMON CLINICAL TRIAL PROTOCOL AND SHARED PLACEBO GROUPS TO ALLOW A GREATER NUMBER OF THERAPIES TO BE TESTED IN LESS TIME WITH LESS EXPENSE THAN BY CONDUCTING MULTIPLE INDEPENDENT TRIALS. THIS TRIAL WILL TEST 5 THERAPEUTIC HYPOTHESES INVOLVING COMBINATIONS OF 3 DRUGS VERSUS PLACEBO: TWO TAU THERAPIES WILL BE STUDIED IN A 2 X 3 FACTORIAL DESIGN (PLACEBO VS. ANTI-AMYLOID [N=2] X TWO TAU THERAPIES OR PLACEBO [N=3]) FOR 24 MONTHS, IN SIX PARALLEL ARMS. THE KEY INCLUSION CRITERIA FOR ATP WILL BE >20 CENTILOIDS OF AMYLOID PET UPTAKE, 18F MK6240 TEMPORAL ROI SUVR >1.25, WITH A GLOBAL CLINICAL DEMENTIA RATING (CDR) OF 0 OR 0.5 AND MMSE >23. USING THESE CRITERIA, WE ESTIMATE THAT 150 PARTICIPANTS PER ARM WILL BE NECESSARY TO HAVE 80% POWER TO DETECT A 30% SLOWING IN THE ACCUMULATION 18F MK6240 SIGNAL OVER 24 MONTHS OF BLINDED THERAPY. KEY SECONDARY ENDPOINTS WILL BE CHANGES IN PLASMA P-TAU SPECIES (-217, ETC.) AND NEUROFILAMENT LIGHT CHAIN (NFL), CLINICAL RATING SCALES AND VOLUMETRIC MRI. LEVERAGING THE EXPERIENCE AND RESOURCES OF THE NIH AD CLINICAL TRIAL CONSORTIUM (ACTC), WE PROPOSE TO ENROLL 900 PARTICIPANTS AT ~100 ACTC SITES OVER 24 MONTHS, RANDOMIZE THEM 5:1 DRUG:PLACEBO FOR 24 MONTHS OF BLINDED TREATMENT, FOLLOWED BY A 24 MONTH OPEN LABEL EXTENSION. WE AIM TO: 1) TEST THE ABILITY OF TWO TAU-DIRECTED THERAPIES, EITHER ALONE OR IN COMBINATION WITH AN ANTI-AMYLOID THERAPY, TO SLOW THE ACCUMULATION OF TAU PET SIGNAL OVER 24 MONTHS AS COMPARED TO PLACEBO OR ANTI-AMYLOID THERAPY ALONE; 2) TEST THE SAFETY AND TOLERABILITY OF 24 MONTHS OF BLINDED THERAPY FOLLOWED BY AN OPTIONAL 24 MONTH OPEN LABEL EXTENSION OF COMBINATION TAU/ANTI-AMYLOID THERAPY; AND 3) EXPLORE THE ABILITY OF EACH OF TWO TAU DIRECTED THERAPIES TO SLOW DISEASE PROGRESSION AS MEASURED BY CSF AND PLASMA BIOMARKERS (PLASMA P-TAU, NFL), VOLUMETRIC MRI AND CLINICAL ASSESSMENTS (PRECLINICAL ALZHEIMER’S COMPOSITE [PACC], ETC.). IF SUCCESSFUL, THE ATP WILL PROVIDE DATA FOR DECISION-MAKING ABOUT WHICH TAU THERAPIES OR COMBINATIONS TO PURSUE IN LARGER EFFICACY STUDIES, AN ONGOING RESOURCE TO TEST NEW THERAPEUTIC APPROACHES BEYOND TAU, AND WILL IMPROVE UNDERSTANDING OF AD BIOLOGY.health
2026-04-22U.S. COMMITTEE FOR REFUGEES AND IMMIGRANTS, INC.Department of Health and Human Services$60,663,512RESIDENTIAL (SHELTER AND/OR TRANSITIONAL FOSTER CARE) SERVICES FOR UNACCOMPANIED CHILDREN - LICENSED AND TEXAS-EXEMPT AND FLORIDA-DELICENSED ONLYsocial-services
2026-03-20NEW HAMPSHIRE DEPARTMENT OF HEALTH & HUMAN SERVICESDepartment of Health and Human Services$60,655,445STATE OPIOID RESPONSE - THROUGH THE NH STATE OPIOID RESPONSE (SOR) 2024, THE NH DEPARTMENT OF HEALTH AND HUMAN SERVICES WILL INCREASE SERVICES FOR YOUTH AND ADULTS WITH OR AT RISK OF DEVELOPING A SUBSTANCE USE DISORDER (SUD) STATEWIDE. THE CONTINUED FOCUS OF SOR IN NH WILL BE IN ALL REGIONS OF THE STATE, CONTINUING TO CREATE ACCESS TO PREVENTION, HARM REDUCTION, TREATMENT, AND RECOVERY FOR PEOPLE WITH ALL TYPES OF SUBSTANCE USE, SPECIFICALLY FOCUSED ON OPIOID USE DISORDER AND STIMULANT USE DISORDER (O/STIMUD), AS WELL AS ADDRESSING ASSOCIATED CO-MORBIDITIES SUCH AS MENTAL HEALTH, AND PHYSICAL HEALTH, INCLUSIVE OF INFECTIOUS DISEASES. WHILE SERVICES WILL BE MADE AVAILABLE TO ANYONE SEEKING ASSISTANCE IN NH, SPECIAL POPULATIONS WILL REMAIN A PRIORITY. THESE SPECIAL POPULATIONS INCLUDE YOUTH AND YOUNG ADULTS (16-25 YEARS OLD) AND THEIR FAMILIES; OLDER ADULTS; PREGNANT AND PARENTING PEOPLE; INDIVIDUALS WITH OR AT RISK OF HIV/AIDS; THE LGBTQA+ COMMUNITY; CHILDREN, YOUTH AND FAMILIES IMPACTED BY SUD, INCLUDING KINSHIP AND FOSTER CARE FAMILIES; INDIVIDUALS INVOLVED WITH THE JUSTICE SYSTEM; AND THOSE RE-ENTERING THE COMMUNITY POST-INCARCERATION. ADDITIONALLY, NH WILL ADDRESS THE UNIQUE SERVICE NEEDS OF HISTORICALLY UNDERSERVED AND UNDERREPRESENTED POPULATIONS, INCLUDING BUT NOT LIMITED TO RACIAL AND ETHNIC MINORITY GROUPS AND INDIVIDUALS WHO HAVE COMMUNICATION ACCESS NEEDS. IN COORDINATION WITH ALL CURRENT STATE AND FEDERAL FUNDING, SOR INITIATIVES ACROSS NH CONTINUE TO ADDRESS ONGOING CHALLENGES AND COMPLEMENT MULTI-SECTOR EFFORTS ACROSS THE CONTINUUM. NH ANTICIPATES SERVING APPROXIMATELY 6,350 UNDUPLICATED INDIVIDUALS ANNUALLY. NH REQUESTS THE FULL FUNDING AVAILABLE, $29,880,604 ANNUALLY AND INTENDS TO USE THIS GRANT TO SUPPORT ACCESS TO CRITICAL SERVICES THAT ARE NOT ACCESSIBLE FOR POPULATIONS DUE TO INSURANCE COVERAGE BARRIERS, SERVICE CAPACITY GAPS, AND WORKFORCE SHORTAGES. EXAMPLES OF THESE SERVICES INCLUDE MEDICATIONS FOR SUBSTANCE USE DISORDER, PREVENTION MESSAGING, TRAINING, WORKFORCE READINESS OPPORTUNITIES, AND SUPPORT SERVICES THAT INCREASE TREATMENT INITIATION, ENGAGEMENT, AND RETENTION (CHILDCARE, TRANSPORTATION). NH WILL USE THE GOVERNMENT PERFORMANCE AND RESULTS ACT (GPRA) DATA COLLECTION AND NOTICE OF FUNDING OPPORTUNITY (NOFO) FOLLOW-UP REQUIREMENTS TO IDENTIFY THE OUTCOMES OF EACH INITIATIVE FUNDED WITH SOR RESOURCES TO INFORM SUSTAINABILITY PLANS. ALL OF THE PROJECTS PROPOSED MEET THE INTENT OF THE NOFO BY INCREASING ACCESS TO MEDICATIONS FOR SUBSTANCE USE DISORDERS, SUPPORTING THE CONTINUUM OF PREVENTION, HARM REDUCTION, TREATMENT, AND RECOVERY SUPPORT SERVICES FOR OUD AND OTHER CONCURRENT SUBSTANCE USE DISORDERS, AND SUPPORTS THE CONTINUUM OF CARE FOR O/STIMUD INCLUDING THOSE INVOLVING COCAINE AND METHAMPHETAMINE.health
2026-04-06JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC.Department of Health and Human Services$60,555,044PEDIATRIC EYE DISEASE INVESTIGATOR GROUP NETWORKhealth
2026-04-22TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THEDepartment of Health and Human Services$60,372,420ALZHEIMER'S DISEASE GENETICS CONSORTIUMbiotech
2026-04-06VALLEY-WIDE HEALTH SYSTEMSDepartment of Health and Human Services$60,277,668HEALTH CENTER CLUSTERhealth
2026-05-05COMMUNITY HEALTH CENTER OF LUBBOCKDepartment of Health and Human Services$60,247,257HEALTH CENTER CLUSTERhealth
2026-03-05BAKERRIPLEYDepartment of Health and Human Services$60,106,493HEAD START AND EARLY HEAD STARTsocial-services
2026-05-05UNIVERSITY OF OKLAHOMADepartment of Health and Human Services$60,096,875OKLAHOMA SHARED CLINICAL AND TRANSLATIONAL RESOURCEShealth
2026-05-05BLUE RIDGE COMMUNITY HEALTH SERVICES, INC.Department of Health and Human Services$60,060,471HEALTH CENTER CLUSTERhealth
2026-03-20ALLIANCE FOR COMMUNITY EMPOWERMENT, INC.Department of Health and Human Services$59,992,040HEAD START AND EARLY HEAD STARTsocial-services
2026-03-20PUBLIC HEALTH, CALIFORNIA DEPARTMENT OFDepartment of Health and Human Services$59,970,118HIGH-IMPACT PREVENTION AND SURVEILLANCE PROGRAMS FOR HEALTH DEPARTMENTS - THIS APPLICATION IS FOR THE FIVE-YEAR FUNDING OPPORTUNITY ANNOUNCEMENT FOR HEALTH DEPARTMENTS TO IMPLEMENT AN INTEGRATED AND COMPREHENSIVE HIV SURVEILLANCE AND PREVENTION PROGRAM TO PREVENT NEW HIV INFECTIONS AND ACHIEVE VIRAL SUPPRESSION AMONG PERSONS LIVING WITH HIV. THIS PROJECT WILL PROMOTE AND SUPPORT IMPROVING HEALTH OUTCOMES FOR PERSONS LIVING WITH HIV THROUGH ACHIEVING AND SUSTAINING VIRAL SUPPRESSION. ACTIVITIES WILL FOCUS ON REDUCING HEALTH-RELATED DISPARITIES BY USING QUALITY, TIMELY, AND COMPLETE SURVEILLANCE AND PROGRAM DATA TO GUIDE HIV PREVENTION EFFORTS. THESE CORE ACTIVITIES CAN BE CONTAINED WITHIN TWO CATEGORIES: (1) PROGRAM PREVENTION; AND (2) PROGRAM SURVEILLANCE. HIV PREVENTION AND SURVEILLANCE PROGRAMS WILL FOCUS ON THE PREVENTION OF NEW HIV INFECTIONS TO IMPROVE THE HEALTH OF PEOPLE WITH HIV. THIS PROJECT WILL INTEGRATE THE WORK OF THE OFFICE OF AIDS’S (OA) HIV SURVEILLANCE AND PREVENTION EVALUATION AND REPORTING (SPER) BRANCH AND HIV PREVENTION BRANCH TO ADDRESS THE EMERGING SYNDEMIC OF HIV, HCV, AND STIS IN CALIFORNIA, AS OUTLINED IN THE 2022-2026 ENDING THE EPIDEMICS: ADDRESSING HIV, HCV, AND STIS IN THE CALIFORNIA STRATEGIC PLAN. THROUGH THIS PLAN, CALIFORNIA ADDRESSES HIV AS A SYNDEMIC WITH HCV AND OTHER STIS THOUGH A SOCIAL DETERMINANTS OF HEALTH LENS, HIGHLIGHTING: A) RACIAL EQUITY, B) HOUSING, C) ACCESS TO HEALTHCARE, D) MENTAL HEALTH AND SUBSTANCE USE, E) ECONOMIC JUSTICE, AND F) STIGMA. OA WILL IMBED THESE PRACTICES INTO SERVICE DELIVERY TO IMPROVE HEALTH EQUITY EFFORTS IN FUNDED JURISDICTIONS BY COORDINATING THESE APPROACHES TO HIV PREVENTION AND TREATMENT RESULTING IN POSITIVE HEALTH OUTCOMES FOR ALL. THE CALIFORNIA EHE PLAN WILL COORDINATE THE WORK OF SIX PHASE I EHE COUNTIES THROUGH 2029: BUILDING ON AND UPDATING THEIR EXISTING EHE PLANS ANNUALLY. THE SIX PHASE I COUNTIES COMPRISE THE CALIFORNIA CONSORTIUM: ALAMEDA, ORANGE, RIVERSIDE, SACRAMENTO, SAN BERNARDINO, AND SAN DIEGO. THE SIX COUNTIES ARE IN VARIOUS GEOGRAPHIC REGIONS AND HAVE DIFFERING PREVENTION NEEDS FOR THEIR DISTINCT POPULATIONS. THUS, CALIFORNIA WILL MAINTAIN AN EHE COORDINATOR AT THE STATE-LEVEL AS WELL AS IN EACH ONE OF THE SIX CALIFORNIA CONSORTIUM COUNTIES. THE WORK OF OUR EHE PLAN WILL: INCREASED LOCAL AVAILABILITY AND ACCESSIBILITY OF INNOVATIVE HIV TESTING SERVICES RESULTING IN INCREASED HIV SCREENING AND ANNUAL RESCREENING AMONG EHE PRIORITY POPULATIONS; BUILD THE CAPACITY FOR RAPID LINKAGE TO CARE, ART AND PREP IN A STATUS-NEUTRAL FRAMEWORK, TO BETTER SERVE EHE PRIORITY POPULATIONS AT THE INTERSECTION OF MENTAL HEALTH, SUBSTANCE USE AND HOUSING STATUS IN EHE COUNTIES; BUILD THE CAPACITY OF EHE COUNTIES TO USE NOVEL, EVIDENCED BASED APPROACHES TO LINK CLIENTS TO PREP/PEP; ENHANCE DATA TO CARE RESPONSE FOR EHE PRIORITY POPULATIONS; AND ENHANCE COMMUNITY ENGAGEMENT TO RECRUIT NEW VOICES AND NON-TRADITIONAL PARTNERS TO THE HIV/STIC/HCV PLANNING TABLE AND TO CONTINUOUSLY IMPROVE EHE INTERVENTIONS.health
2026-03-20CITY OF NEW YORKDepartment of Health and Human Services$59,969,557STRENGTHENING STD PREVENTION AND CONTROL FOR HEALTH DEPARTMENTS (STD PCHD).health
2026-04-06HEALTH SERVICES INCDepartment of Health and Human Services$59,923,758HEALTH CENTER CLUSTERhealth
2026-04-20HEALTH SERVICES KENTUCKY CABINET FORDepartment of Health and Human Services$59,829,474RYAN WHITE CARE ACT TITLE IIhealth
2026-04-06UNIVERSITY OF ARIZONADepartment of Health and Human Services$59,754,489PRECISION AGING NETWORK: CLOSING THE GAP BETWEEN COGNITIVE HEALTHSPAN ANDHUMAN LIFESPAN - SUMMARY/ABSTRACT: OVERALL PROJECT THE STRATEGIC VISION OF THE PRECISION AGING NETWORK (PAN) IS TO DEVELOP THE ESSENTIAL SCIENTIFIC KNOWLEDGE TO UNDERSTAND THE DISCREPANCY THAT CURRENTLY EXISTS BETWEEN COGNITIVE HEALTHSPAN AND HUMAN LIFESPAN. WE MUST REVEAL THE NEURAL MECHANISMS THAT 1) ACCOUNT FOR OPTIMAL BRAIN PERFORMANCE IN OLD AGE RESULTING IN HEALTHY COGNITIVE FUNCTION, AND 2) THOSE THAT UNDERLIE DECLINE IN BRAIN FUNCTION LEADING TO AGE-RELATED COGNITIVE IMPAIRMENT (ARCI), ALZHEIMER’S DISEASE (AD), OR ALZHEIMER’S DISEASE-RELATED DEMENTIAS (ADRD). THE ULTIMATE GOAL OF THE PAN IS TO DEVELOP NOT ONLY A STRONG SCIENTIFIC FOUNDATION FOR THE ESSENTIAL KNOWLEDGE NEEDED TO MATCH COGNITIVE HEALTHSPAN WITH HUMAN LIFESPAN, BUT ALSO TO LEVERAGE BIG DATA APPROACHES THAT APPLY PRECISION MEDICINE CONCEPTS TO PROLONG OPTIMAL BRAIN FUNCTION. TO ACHIEVE THIS GOAL OF SUSTAINING OPTIMAL COGNITIVE FUNCTION IN OLD AGE, AND TO EXTEND QUALITY OF LIFE FOR PEOPLE ACROSS LEVELS OF RISK FOR ARCI, AD, OR ADRD, WE MAINTAIN THAT METHODOLOGIES SUCH AS THOSE DEVELOPED AND IMPLEMENTED IN THE PAN WILL BE REQUIRED. ALTHOUGH ‘CHRONOLOGICAL AGE’ IS CONSISTENTLY ASSOCIATED WITH INCREASING INCIDENCE OF DISABILITY, INCLUDING CHRONIC BRAIN DISORDERS SUCH AS AD AND ADRD, THE EXACT MECHANISTIC RELATIONSHIPS BETWEEN ‘BIOLOGICAL AGE’ AND DECLINE IN BRAIN FUNCTION IS NOT KNOWN. THE NUMBER OF PEOPLE NOW LIVING WITH SOME FORM OF DEMENTIA IS ESTIMATED TO BE 50 MILLION WORLDWIDE, WHICH IS EXPECTED TO DOUBLE EVERY 20 YEARS. BECAUSE OF THE ENORMOUS HETEROGENEITY IN BRAIN AND COGNITIVE FUNCTION AMONG INDIVIDUALS IN THEIR 70S, 80S AND 90S, THE URGENT CHALLENGE FOR SCIENCE, MEDICINE AND HEALTHCARE PROVIDERS IS TO DISCOVER INTERVENTIONS THAT ARE INDIVIDUALLY EFFECTIVE IN DELAYING OR PREVENTING ARCI, AD, OR ADRD. UNTANGLING THE COMPLEX RELATIONSHIP BETWEEN AGE AND COGNITIVE PERFORMANCE REQUIRES A STRATEGY THAT INCLUDES THE STUDY OF VERY LARGE, DIVERSE, WELL-CHARACTERIZED AND LONGITUDINALLY SAMPLED POPULATIONS. THIS WILL REQUIRE ‘BIG DATA’ BUT ALSO THE MEANS TO TRANSLATE THE MASSIVE AMOUNTS OF INFORMATION GATHERED INTO ‘SMART DATA’ OR ‘KNOWLEDGE’. THIS DEMANDS RADICALLY DIFFERENT CONCEPTUAL MODELS. CURRENTLY, NO SINGLE APPROACH ADEQUATELY IDENTIFIES THE MEANS TO MODIFY PERSONAL AGING TRAJECTORIES FOR IMPROVED BRAIN HEALTH IN INDIVIDUALS. THE APPROACH PROPOSED IN PAN IS DESIGNED TO OVERCOME OBSTACLES OF EARLIER METHODS. THE FOCUS IS ON HOW TO DISTINGUISH THE VARIOUS COMBINATIONS OF AGE, SEX, GENETICS, RACE-ETHNICITY, HEALTH, LIFESTYLE CHOICES AND ENVIRONMENTAL FACTORS THAT INFLUENCE BRAIN DRIVERS THAT INCREASE SUSCEPTIBILITY TO DYSFUNCTION, AS WELL AS THOSE FACTORS THAT INCREASE BRAIN PROTECTION AND RESISTANCE AGAINST DYSFUNCTION. THE FUNDAMENTAL PRINCIPLE OF THE PRECISION MEDICINE APPROACH IS TO ’INDIVIDUALIZE’. THIS WILL ENABLE STRONG AND SPECIFIC PREDICTIONS FOR EACH PERSON TO CLOSE THE GAP BETWEEN COGNITIVE HEALTHSPAN AND HUMAN LIFESPAN. THE ROOT OF THIS CONCEPT IS IN THE TEACHINGS OF HIPPOCRATES, WHO SAID – “IT IS MORE IMPORTANT TO KNOW WHAT SORT OF PERSON HAS A DISEASE THAN TO KNOW WHAT SORT OF DISEASE A PERSON HAS.”biotech
2026-04-20OHIO DEPARTMENT OF CHILDREN AND YOUTHDepartment of Health and Human Services$59,605,958CCDF-2026 - CHILD CARE AND DEVELOPMENT FUND MANDATORY & MATCHINGsocial-services
2026-04-20NORTH CAROLINA DEPARTMENT OF HEALTH & HUMAN SERVICESDepartment of Health and Human Services$59,515,321CCDM-2026 - CHILD CARE AND DEVELOPMENT FUND -- STATE MATCHINGsocial-services
2026-03-20BARRIO COMPREHENSIVE FAMILY HEALTH CARE CENTER, INC.Department of Health and Human Services$59,477,901HEALTH CENTER CLUSTERhealth
2026-02-27TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THEDepartment of Health and Human Services$59,273,750AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)biotech
2026-04-20NORTH CAROLINA DEPARTMENT OF HEALTH & HUMAN SERVICESDepartment of Health and Human Services$59,193,344CCDF-2026 - CHILD CARE AND DEVELOPMENT FUND MANDATORY & MATCHINGsocial-services
2026-05-05BOTSWANA-UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE HEALTH INITIATIVESDepartment of Health and Human Services$59,144,763ACCELERATING BOTSWANA THROUGH THE LAST MILE TO EPIDEMIC CONTROL (ABLE) PROJECThealth
2026-05-05NORTH EAST MEDICAL SERVICESDepartment of Health and Human Services$58,854,310HEALTH CENTER CLUSTERhealth
2026-04-20COMMUNITY HEALTH ASSOCIATION OF SPOKANEDepartment of Health and Human Services$58,755,889HEALTH CENTER CLUSTERhealth
2026-04-20LVCT HEALTHDepartment of Health and Human Services$58,724,520VUKISHA 95:TRANSITIONING COMPREHENSIVE HIV PROGRAMS TO COUNTIES TO ACHIEVE UNAIDS 95-95-95 GOALShealth
2026-05-05JWCH INSTITUTE, INC.Department of Health and Human Services$58,721,228HEALTH CENTER CLUSTERhealth
2026-02-17SERVEFED INC.Department of Health and Human Services$58,712,173CLINICAL EAST OCCUPATIONAL HEALTH SUPPORT SERVICEShealth
2026-05-05PCC COMMUNITY WELLNESS CENTERDepartment of Health and Human Services$58,676,935HEALTH CENTER CLUSTERhealth
2026-04-06NEBRASKA DEPARTMENT OF HEALTH & HUMAN SERVICESDepartment of Health and Human Services$58,549,977FOSTER-2026 - FOSTER CAREsocial-services
2026-04-06COMMONWEALTH OF MASSACHUSETTS DEPT OF CHILDREN & FAMILIESDepartment of Health and Human Services$58,521,945ADPTASST-2026 - ADOPTION ASSISTANCEsocial-services
2026-04-06LAWNDALE CHRISTIAN HEALTH CENTERDepartment of Health and Human Services$58,453,491HEALTH CENTER CLUSTERhealth
2026-04-06HEALTH AND HUMAN SERVICES, MAINE DEPARTMENT OFDepartment of Health and Human Services$58,397,3192026 TANFsocial-services
2026-04-20FAMILY RESOURCE AGENCY INCDepartment of Health and Human Services$58,276,587HEAD START AND EARLY HEAD STARTsocial-services
2026-03-18BOOZ ALLEN HAMILTON INCDepartment of Health and Human Services$58,260,870DCIPHER SERVICEShealth
2026-04-20DEPARTMENT OF JUSTICE CALIFORNIADepartment of Health and Human Services$58,239,669MEDICAID FRAUD CONTROL UNIT - TO INVESTIGATE AND PROSECUTE MEDICAID PROVIDER FRAUD AS WELL AS PATIENT ABUSE OR NEGLECT IN HEALTH FACILITIES AND BOARD AND CARE FACILITIES AND OF MEDICAID BENEFICIARIES IN NON-INSTITUTIONAL OR OTHER SETTINGS.health
2026-05-05THE NEAR NORTH HEALTH SERVICE CORPORATIONDepartment of Health and Human Services$58,111,553HEALTH CENTER CLUSTERhealth
2026-05-05GARDNER FAMILY HEALTH NETWORK, INCDepartment of Health and Human Services$58,038,448HEALTH CENTER CLUSTERhealth
2026-04-06NEW YORK UNIVERSITYDepartment of Health and Human Services$57,994,0841 OF 5 ARIC NEUROCOGNITIVE STUDY (ARIC-NCS)health
2026-04-22UNISSANT INC.Department of Health and Human Services$57,970,503ELECTRONIC SUBMISSION OF MEDICAL DOCUMENTATION (ESMD)health
2026-04-20DEPARTMENT OF HUMAN RIGHTS IOWADepartment of Health and Human Services$57,958,949LIHEAP-2026 - LOW INCOME HOME ENERGY ASSISTANCEsocial-services
2026-04-20THE JOHNS HOPKINS UNIVERSITYDepartment of Health and Human Services$57,926,840NORTH AMERICAN AIDS COHORTS COLLABORATION ON RESEARCH AND DESIGNhealth
2026-04-20SALK INSTITUTE FOR BIOLOGICAL STUDIES, SAN DIEGO, CALIFORNIA, THEDepartment of Health and Human Services$57,772,833CANCER CENTER SUPPORT GRANTbiotech
2026-04-22LUSAKA PROVINCIAL HEALTH OFFICEDepartment of Health and Human Services$57,675,833SUSTAINING THE CAPACITY OF PROVINCIAL HEALTH OFFICES (PHO) TO COORDINATE AND PROVIDE QUALITY, COMPREHENSIVE AND SUSTAINABLE HIV/AIDS PREVENTION, CARE AND TREATMENT - PROJECT ABSTRACT SUMMARY THIS NEW FIVE YEAR PROJECT APPLICATION WILL SUPPORT LPHO TO MAINTAIN, SUSTAIN, AND BUILD UPON THE ACHIEVEMENTS MADE TO DATE IN THE HIV PROGRAM IN THE PROVINCE. DURING THE PROJECT CYCLE, LUSAKA PROVINCIAL HEALTH OFFICE (LPHO) WILL PROVIDE PROGRAMMATIC OVERSIGHT, COORDINATION, AND DIRECT SERVICE DELIVERY (DSD) IN THE PROVISION OF COMPREHENSIVE HIV PREVENTION, TREATMENT AND SUPPORT SERVICES, WHILE STRENGTHENING HEALTH SYSTEMS FOR SUSTAINABILITY BY SEPTEMBER 2027. FOR THIS PROJECT, BROAD AREAS OF SUPPORT, WHICH INCLUDE, BUT NOT LIMITED TO: " HIV PREVENTION SERVICES: VOLUNTARY MEDICAL MALE CIRCUMCISION (VMMC); CERVICAL CANCER (CXCA) PREVENTION AND TREATMENT; GENDER BASED VIOLENCE (GBV) PREVENTION AND RESPONSE; CONDOM PROGRAMMING; PRE-EXPOSURE PROPHYLAXIS (PREP); ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION (EMTCT); SUPPORT FOR KEY AND VULNERABLE POPULATIONS (KVPS) AND ORPHANS AND VULNERABLE CHILDREN (OVCS); " HIV TREATMENT AND SUPPORT SERVICES FOR ALL AGE GROUPS ACROSS THE CARE CONTINUUM FROM CASE FINDING TO VIRAL LOAD (VL) SUPPRESSION. SUPPORT WILL INCLUDE: PREVENTION AND MANAGEMENT OF OPPORTUNISTIC INFECTIONS (OIS) AND ADVANCED HIV DISEASE (AHD), AS WELL AS NON-COMMUNICABLE DISEASES (NCDS) (INCLUDING SUPPORT FOR MENTAL HEALTH); " HEALTH SYSTEM STRENGTHENING INCLUDING SUPPORT TO FINANCIAL AND ADMINISTRATIVE MANAGEMENT SYSTEMS, INTERNAL CONTROLS, HUMAN RESOURCES FOR HEALTH (HRH), SUPPLY CHAIN/COMMODITIES MANAGEMENT, LABORATORY SERVICES, AND CONTINUOUS QUALITY IMPROVEMENT (CQI). " IMPLEMENT HI SYSTEMS TO FACILITATE ACCESS AND USE OF QUALITY DATA TO INFORM PROGRAM IMPROVEMENT AT ALL LEVELShealth
2026-04-06DEPARTMENT OF SOCIAL SERVICES MISSODepartment of Health and Human Services$57,669,699ADPTASST-2026 - ADOPTION ASSISTANCEsocial-services
2026-04-06DEPARTMENT OF HUMAN SERVICES COLORADODepartment of Health and Human Services$57,634,917FOSTER-2026 - FOSTER CAREsocial-services
2026-04-06NYS DEPARTMENT OF HEALTHDepartment of Health and Human Services$57,631,350NEW YORK STATE (NYS) COMPREHENSIVE FAMILY PLANNING AND REPRODUCTIVE HEALTH PROGRAM (FPP)health
2026-03-05PANCARE OF FLORIDA, INC.Department of Health and Human Services$57,602,711HEALTH CENTER CLUSTERhealth
2026-04-06FLORIDA DEPARTMENT OF HEALTHDepartment of Health and Human Services$57,589,452FLORIDA TITLE X STATEWIDE FAMILY PLANNING PROJECThealth
2026-04-06UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLDepartment of Health and Human Services$57,551,079UNC CENTER FOR AIDS RESEARCHbiotech